# Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia

> **NCT01845649** · PHASE3 · COMPLETED · sponsor: **Warner Chilcott** · enrollment: 550 (actual)

## Conditions studied

- Vulvovaginal Atrophy

## Interventions

- **DRUG:** WC3011 Estradiol Vaginal Cream
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT01845649
- **Lead sponsor:** Warner Chilcott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-12
- **Primary completion:** 2013-11-20
- **Final completion:** 2013-11-20
- **Target enrollment:** 550 (ACTUAL)
- **Last updated:** 2022-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01845649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01845649, "Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women With Dyspareunia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01845649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*